JCR PHARMACEUTICALS CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 797 JPY | +0.50% |
|
+2.05% | -32.00% |
| Mar. 21 | US Fed Rate Outlook Catapults Japanese Shares to Fresh 52-Week Peak | MT |
| Mar. 21 | JCR Pharmaceuticals Achieves Neurodegenerative Treatment Research Milestone With Alexion | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
JCR Pharmaceuticals Co., Ltd. is a Japan-based company primarily engaged in the pharmaceutical business, as well as the medical and research equipment business. The Company operates in two segments. The Pharmaceutical segment engages in the research, production, purchase and sale of medical drugs and pharmaceutical raw materials. The Medical and Research Equipment segment engages in the purchase and sale of the medical and research equipment.
Sector
Pharmaceuticals
Calendar
2024-05-09
- Q4 2023 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
797
JPY
Average target price
1,557
JPY
Spread / Average Target
+95.38%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -32.00% | 632M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- 4552 Stock
- News JCR Pharmaceuticals Co., Ltd.
- JCR Pharmaceuticals Achieves Neurodegenerative Treatment Research Milestone With Alexion
